• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Father sues Intuitive Surgical for botched da Vinci hysterectomy

Father sues Intuitive Surgical for botched da Vinci hysterectomy

April 5, 2012 By MassDevice staff

Intuitive Surgical logo

The father of a 24-year-old woman who died 2 weeks after undergoing a hysterectomy with the da Vinci surgical robot filed a lawsuit against device maker Intuitive Surgical (NSDQ:ISRG) on the grounds that the system led to her death.

Gilmore McCalla also claims that Intuitive Surgical "has suppressed reports of complications, and has oversold the merits of its da Vinci robot to hospitals considering buying it."

The news has yet to slow the ever-increasing value of ISRG stock, which was up about 0.3% to $545.55 around 3 p.m. today, but the lawsuit may represent a hurdle for the company moving forward.

In a lawsuit filed in a New York court, McCalla said that the da Vinci system burned an artery and intestines during his daughter’s surgery, further accusing the surgeon and the hospital of carelessness for not discovering the damage.

McCalla claimed that the surgical robot contains dangerous design flaws, including un-insulated surgical arms that may allow electrical currents to jump to healthy internal organs and tissue. He also said that Intuitive didn’t properly train physicians to use the device, according to a press release.

The Sunnyvale, Calif.-based device maker has a corner on the robot-assisted surgery market, recently adding gall bladder surgery to its list of FDA-approved indications. The machine, which features a console through which a physician can manipulate robotic arms with surgical tools, has become the preferred option in prostatectomy and is gaining ground in hysterectomies.

The company’s star has been soaring on Wall Street, but questions about da Vinci’s cost-to-benefit ratio have created some skeptics.

"The cost for performing robotic surgery greatly exceeds the type of laparoscopic or open surgery it replaces, and there has been debate in the medical literature whether the extra costs – whether paid by insurance companies, the government or patients – is justified because of claimed better outcomes with the device," according the lawsuit, which alleges that "Intuitive Surgery has not sponsored any comparative safety tests where patients are selected prospectively as compared to just looking at results."

According to a study published in the Journal of Clinical Oncology in January, complication rates for women with endometrial cancer were roughly the same after standard laparoscopy and robot-assisted surgery, although the robotic procedures each cost about $1,300 more.

"It turns out that the paper actually entirely misses the point, in that it compares laparoscopic to robotics, but the reality is that what’s happening in the market is robotics are converting open procedures to robotic procedures," Intuitive CEO Gary Guthart told MassDevice in an exclusive interview last month. "If you look at that comparison, which is what’s really happening, the economics are easy to describe."

"For the patient, it’s pretty straightforward," he added. "The return to full function versus an open procedure is faster with robotics, the complication rate is lower with robotics versus open and the patient doesn’t pay any more out of pocket, because it is typically a covered benefit."

Filed Under: Legal News, News Well, Surgical Robotics, Women's Health Tagged With: Intuitive Surgical

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy